foscarnet has been researched along with valganciclovir in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 20 (60.61) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hoffman, VF; Skiest, DJ | 1 |
| Salmon-Ceron, D | 1 |
| Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
| Bodaghi, B; Cassoux, N; Davis, JL; de Schryver, I; Kestelyn, P; Lehoang, P; Michelson, S; Rozenberg, F | 1 |
| Michaels, MG | 1 |
| Boucher, HW; Torres-Madriz, G | 1 |
| Járay, J; Péter, A; Telkes, G; Varga, M | 1 |
| Bunjes, D; Härter, G; Mertens, T; Michel, D; Schreiber, A; Schubert, A | 1 |
| Burgos, D; Cabello, M; González Molina, M; Gutiérrez, C; López, V; Siles, J; Sola, E; Vega, E | 1 |
| Chan-Kai, BT; Chew, EY; Faia, LJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Weichel, ED; Witherspoon, SR; Wong, WT; Yeh, S | 1 |
| Kern, ER; Prichard, MN | 1 |
| Razonable, RR | 2 |
| Fahle, G; Faia, LJ; Flaxel, CJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Stout, JT; Weichel, ED; Yeh, S | 1 |
| Dickson, M; Eliadou, E; Ferguson, P; Goossens, L; Stace, NH; Weinkove, R | 1 |
| Brichová, M; Dvořák, J; Heissigerová, J; Kalvodová, B; Ríhová, E; Svozílková, P | 1 |
| Albini, TA; Flaxel, CJ; Gupta, S; Mandelcorn, E; Suhler, EB; Vemulakonda, GA; Yeh, S | 1 |
| Eliott, D; Elner, SG; Goldberg, N; Johnson, MW; Lieberman, RM; Schneider, EW; van Kuijk, FJ | 1 |
| Goumenos, DS; Kalliakmani, P; Koukoulaki, M; Marangos, M; Papachristou, E; Papasotiriou, M; Savvidaki, E | 1 |
| Ablashi, DV; Arbuckle, JH; Hu, J; Luka, J; Medveczky, MM; Medveczky, PG; Montoya, JG; Pantry, SN; Peterson, D; Pritchett, JC; Renne, R | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Agut, H; Aït-Arkoub, Z; Autran, B; Boutolleau, D; Burrel, S; Carcelain, G; Conan, F; Deback, C; Gandjbakhch, I; Varnous, S | 1 |
| Albini, TA; Churgin, D; Davis, JL; Relhan, N | 1 |
| Akkoç, G; Atıcı, S; Bakır, M; Çeliker, H; Demir, SÖ; Kadayifci, EK; Karaaslan, A; Kazokoğlu, H; Koç, A; Şenay, E; Soysal, A; Yakut, N | 1 |
| Angarone, M; Flaherty, J; Ison, MG; Penugonda, S; Rubin, J; Stosor, V; Young, PG | 1 |
| Bernal-Blanco, G; Cintra-Cabrera, M; Fernández-Cuenca, F; Gentil-Govantes, MÁ; González-Roncero, FM; Pérez-Valdivia, MÁ; Rocha-Castilla, JL; Suárez-Benjumea, A; Súñer-Poblet, M; Toapanta-Gaibor, NG | 1 |
| Meesing, A; Razonable, RR | 1 |
| Danziger-Isakov, L; Englund, J; Green, M; Posfay-Barbe, KM; Zerr, DM | 1 |
| Kwong, J; Leung, PYM; Paizis, K; Testro, A; Tran, T; Whitlam, JB | 1 |
| Müller, TF; Näf, B; Rho, E; Schachter, T; von Moos, S; Wüthrich, RP | 1 |
| Alain, S; Alexander, BD; Avery, RK; Blumberg, EA; Chemaly, RF; Cordonnier, C; Duarte, RF; Florescu, DF; Fournier, M; Kamar, N; Kumar, D; Maertens, J; Marty, FM; Papanicolaou, GA; Silveira, FP; Sundberg, AK; Witzke, O; Wu, J | 1 |
| Blumberg, EA; Halpern-Cohen, V | 1 |
17 review(s) available for foscarnet and valganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic developments in cytomegalovirus retinitis.
Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drugs, Investigational; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valganciclovir | 2000 |
Cytomegalovirus infection: the point in 2001.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir | 2001 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
Treatment of congenital cytomegalovirus: where are we now?
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Valganciclovir | 2007 |
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
Topics: Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Transplantation; Valganciclovir | 2008 |
[Gastrointestinal cytomegalovirus infections in organ transplant patients].
Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir | 2008 |
Antiviral treatment of cytomegalovirus infection and resistant strains.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Thionucleotides; Valganciclovir | 2009 |
The search for new therapies for human cytomegalovirus infections.
Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Valganciclovir; Virus Replication | 2011 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease Management; Drug Resistance, Viral; Everolimus; Female; Foscarnet; Ganciclovir; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infant; Male; Middle Aged; Valganciclovir; Viral Load | 2015 |
Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Retinitis; DNA, Viral; Eye; Foscarnet; Ganciclovir; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Valganciclovir; Viremia; Vitreous Body | 2016 |
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Induction Chemotherapy; Kidney Transplantation; Male; Middle Aged; Mutation; Postoperative Complications; Recombinant Fusion Proteins; Tacrolimus; Valganciclovir; Virus Replication | 2018 |
New Developments in the Management of Cytomegalovirus Infection After Transplantation.
Topics: Acetates; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Organ Transplantation; Quinazolines; Valganciclovir | 2018 |
New Perspectives on Antimicrobial Agents: Maribavir.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Benzimidazoles; Child; Cidofovir; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir | 2022 |
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Transplant Recipients; Valganciclovir | 2023 |
1 trial(s) available for foscarnet and valganciclovir
| Article | Year |
|---|---|
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir; Viremia | 2022 |
15 other study(ies) available for foscarnet and valganciclovir
| Article | Year |
|---|---|
Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chronic Disease; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Glaucoma, Open-Angle; Gonioscopy; Humans; Iridocyclitis; Male; Middle Aged; Recurrence; Retrospective Studies; Uveitis, Anterior; Valganciclovir; Vitreous Body | 2006 |
[Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Gastric Mucosa; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Mutation, Missense; Phosphotransferases (Alcohol Group Acceptor); Postoperative Complications; Risk; Valganciclovir; Viral Load | 2009 |
Fundus autofluorescence changes in cytomegalovirus retinitis.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Female; Fluorescein Angiography; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Retinal Pigment Epithelium; Retrospective Studies; Valganciclovir | 2010 |
Polymerase chain reaction-based ganciclovir resistance testing of ocular fluids for cytomegalovirus retinitis.
Topics: Adult; Aged; Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Genome, Viral; Genotype; Humans; Infant; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir; Viral Proteins; Vitreous Body | 2012 |
Fever and pancytopenia in a patient with Crohn's disease.
Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedures; Disease Progression; Female; Fever; Foscarnet; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Ileitis; Ileum; Immunosuppression Therapy; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Pancytopenia; Rectum; Treatment Outcome; Valganciclovir; Young Adult | 2013 |
A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Eye Neoplasms; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Polymerase Chain Reaction; Rituximab; Valganciclovir; Vitrectomy | 2013 |
Cytomegalovirus retinitis in the absence of AIDS.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Immunocompetence; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir | 2013 |
Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; CD4 Lymphocyte Count; Chronic Disease; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Male; Middle Aged; Necrosis; Polymerase Chain Reaction; Retinal Neovascularization; Retinal Vasculitis; Retinal Vessels; Retrospective Studies; Uveitis, Posterior; Valganciclovir; Vitreous Body | 2013 |
Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Polyradiculopathy; Time Factors; Valganciclovir | 2013 |
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.
Topics: Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Infectious Disease Transmission, Vertical; Prevalence; RNA, Viral; Roseolovirus Infections; Sequence Analysis, DNA; Treatment Outcome; United States; Valganciclovir; Virus Replication | 2013 |
Perivascular hypofluorescence in frosted branch angiitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Female; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Intravitreal Injections; Middle Aged; Retinal Vasculitis; Valganciclovir | 2015 |
Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cohort Studies; Communicable Diseases; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Risk Factors; Valganciclovir; Young Adult | 2016 |
Cytomegalovirus in Pediatric Hematopoietic Stem Cell Transplantation: A Case-Based Panel Discussion of Current Challenges.
Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Male; Recurrence; Respiratory Insufficiency; Risk Assessment; Secondary Prevention; T-Lymphocytes, Cytotoxic; Valganciclovir; Viral Load | 2018 |
Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
Topics: Aged; Antiviral Agents; Cytomegalovirus; Drug Resistance, Viral; Foscarnet; Hepatorenal Syndrome; Humans; Kidney Transplantation; Liver Transplantation; Male; Phosphotransferases (Alcohol Group Acceptor); Sequence Deletion; Valganciclovir; Viral Load; Viral Proteins; Virus Replication | 2019 |
Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir | 2021 |